UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Bearing Point Capital LLC

Key Points

• Bearing Point Capital LLC increased its stake in UnitedHealth Group by 9.1% during the first quarter, holding a total of 19,250 shares valued at approximately $10.08 million.
• UnitedHealth Group announced a quarterly dividend increase from $2.10 to $2.21 per share, reflecting an annualized yield of 3.15% as of June 24th, 2023.
• Wall Street analysts have downgraded UnitedHealth Group's stock ratings, with the average target price now set at $392.29, down from previous highs, reflecting cautious sentiment in the market.

Bearing Point Capital LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.1% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,250 shares of the healthcare conglomerate's stock after buying an additional 1,603 shares during the quarter. UnitedHealth Group comprises 2.1% of Bearing Point Capital LLC's investment portfolio, making the stock its 8th biggest holding. Bearing Point Capital LLC's holdings in UnitedHealth Group were worth $10,082,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the fourth quarter valued at about $30,000. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group in the fourth quarter valued at about $41,000. Finally, Copia Wealth Management purchased a new position in UnitedHealth Group in the fourth quarter valued at about $42,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the company's stock in a transaction on Wednesday, May 14th. The stock was bought at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director owned 6,033 shares of the company's stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have purchased a total of 109,408 shares of company stock worth $31,607,768 over the last ninety days. 0.28% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts have issued reports on UNH shares. Raymond James Financial cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research report on Monday, May 19th. Deutsche Bank Aktiengesellschaft dropped their price target on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research report on Wednesday, May 14th. Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Finally, Royal Bank Of Canada decreased their price target on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research note on Friday, May 16th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $392.29.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH traded down $14.22 during midday trading on Tuesday, hitting $267.90. The company's stock had a trading volume of 26,908,385 shares, compared to its average volume of 11,486,181. The stock has a market capitalization of $243.02 billion, a price-to-earnings ratio of 11.22, a PEG ratio of 1.39 and a beta of 0.45. The stock's 50 day simple moving average is $300.91 and its 200 day simple moving average is $422.56. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $5.16 by ($1.08). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.80 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a $2.21 dividend. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.30%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.